Skip to content

Subcutaneous tunneling vs conventional PICC: A randomized controlled trial

Subcutaneous tunneling versus conventional insertion of peripherally inserted central catheter in hospitalized patients (TUNNEL-PICC): A multi-institutional, open-label, parallel-group, pragmatic, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005521
Enrollment
1694
Registered
2020-10-21
Start date
2020-11-16
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Comparison between subcutaneous tunneling group and conventional group in placement of peripherally inserted central catheter.

Sponsors

The Catholic University of Korea, Incheon St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Adult (more than 18 year old) hospitalized patients in needs of PICC ? Patients who agree with participating clinical trial under fully understanding of informed consent.

Exclusion criteria

Exclusion criteria: ? Diagnosis of CLABSI requires more than 48 hours after catheterization. Patients with pending discharge from hospital within 2 days will be excluded.

Design outcomes

Primary

MeasureTime frame
Rate of Central-Line associated Blood Stream Infection; by definition of National Healthcare Safety Network, patients with catheter more than 2 days and microbiologic diagnosis of bloiod stream infection without other infection (eg. mucosal barrier injury-laboratory confirmed bloodstream infection. Rate of CLABSI will be presented with percentage and rate per catheter-day

Secondary

MeasureTime frame
Exit site infection;Bleeding at insertion site;Procedure time;Technical success;Subcutaneous tunnel associated complicataion (bleeding, skin injury, or subcutaneous infection)

Countries

Korea, Republic of

Contacts

Public ContactDong Jae Shim

The Catholic University of Korea, Incheon St. Mary's Hospital

inharad@naver.com+82-2-280-6742

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 13, 2026